Skip to content

Pulse Biosciences, targeted by shorts, finds buy support

May 12, 2017

Short target Pulse Biosciences, Inc. (NASDAQ: PLSE) was ramping mid-day following an amended 13D disclosure showing large holder, Robert Duggan, stepped in with a number of purchases amid the negative report:

Data shows Duggan bought from 04/25-05/11 128,124 shares at prices from $20.96-$24.94 and Genisus Accelerated bought 35,000 shares on 04/28 at $24.00.

Some of these purchases were disclosed in a prior Form 4 filing after the close.


From → Uncategorized

Leave a Comment

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s

%d bloggers like this: